Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Bergenbio, Dragonfly, Glaxosmithkline, Inovio, Moderna, Pharmaxis, Plus.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akeso, Antengene, Astrazeneca, Bharat Biotech International, Biontech, Daiichi Sankyo, GC, Innovent Biologics, Inovio, Kangtai Biological, Merck, Novavax, Nrx, Ocugen, Pfizer, Ridgeback, Transthera Sciences.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: CMR Surgical.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Astrazeneca, Diamedica, Eton, Liquidia, Ocugen, Prelude, Seelos, Soligenix.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Flume Catheter.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Bharat, Novavax, Nrx, Ocugen, Opiant, Tris.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Rewalk Robotics.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Allena, Astrazeneca, BMS, Biontech, Daiichi, Inovio, Effrx, Enlivex, Epizyme, Innovent, Inovio, Kangtai, Lipocine, Macrogenics, Menarini, Merck, Merus, Minerva, Neurona, Novavax, Ocugen, OS, Pfizer, Rafael, Ridgeback, Transthera, Union, Y-mabs.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Insightec, Lumos Diagnostics, Mim Software.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Akebia, Angel, Antengene, Axcella Health, Bharat Biotech International, Biontech, China Oncology Focus, Cocrystal, Coherus, Corvus, Gannex, Immunoforge, Immutep, Impact, Junshi, Merck, Moderna, Novavax, Ocugen, Oramed, Pfizer, RDIF, Recce, Ridgeback, Serum Institute of India, Serum Life Sciences, Sorrento, TFF, Vitti Labs.